Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I do not understand the deaf ears on here it would seem owning Ipix would be a contradiction to their views. Maybe they don’t own any.
I don’t think most on here were expecting any such thing but it does make the Military Health Symposium very intriguing regarding more new data to be released.
SAVE your children and GET VACCINATED.
Not directed at you frenchbroad.
Well that makes sense considering they were tested in the laboratory.
Imo this makes the next presentation very very intriguing. We could get quite a run here.
It is very likely a lot of investors put Ipix on the clock to check in with a month to go before the release of trial results. We are a penny stock with dollars potential which I believe will lead to a rising price ahead of results.
I think it rallied because we are going to completion without hiccups and the price will rocket from here. $108 million market cap but with a successful trial is a $BILLION stock. 10 x today’s price.
What twisted notion are you pushing now. Stick to vaccines and masks only please.
You and your advisor appear to be the only people in the world who don’t understand a blinded trial.
You can’t have it both ways Dunn after all you’ve probably called everyone of those Prs “fluff.”
Ipix prs have not led anybody to believe it’s a sure thing.
Fully agree.
Thanks for taking the time to write that.
I am sure my fellow man feels better about me taking the shots just as I do.
The thought of what’s percolating is the new data soon to be released may show a great expansion of Brilacidin’s uses.
Why on earth would one sell when new data from RBLs could expand Brilacidin’s potential as a therapeutic. It looks as if the field is opening up and we are about to hear a lot more of our non-peptidic mimetic drug.
So you are in the dessert Dunn. Stick your head in the sand if you want but compelling new data will show investors an oasis of green pastures and blue skies ahead.
............... as for myself I bought a few more yesterday as I like the increasing potential for Brilacidin becoming a blockbuster drug curing many diseases.
This crazy idea of yours is just that: crazy.
I apologize for the confusion as of course I should have written “RBL.” GBL is my acronym for Government Bio-labs just as IOM is my acronym for Ipix on the move.
IOM
If we get help from a rule change I would have to be seller as I have never thought short or naked shorts are at work here. Ipix imo stands or falls on it's science not because of schemers.
None of the above changes my mind that Brilacidin could play a part in curing many many deseases.
GBLs beat out all previous revenue sources for their influence alone. Move on just as Ipix is.
In my mind’s eye there is a very big footprint for Brilacidin which, if perceived by new investors, will lead to an increasing share price and a new image for Ipix.
Doesn’t new data on non-sars-cov-2 endemic viral diseases potentially increase the scope for Brilacidin. The news is coming and it WILL be picked up by the scientific press which can only be good for Ipix. Grants coming our way soon?
Yes, sorry Blue Fin I see what you mean.
Leo does not know what we have already, Putin does not know either and that's a fact.
There is little doubt that your post will be subjected to the slings and arrows of the usual take down artists but I really like what you say and am hopeful you are definitely on the right tracts.
With favorable results from the COVID-19 trial the sky is the limit. New data may also provide a look into how Ipix will map out Brilacidin’s future. Alfasigma plays a part in all this too.
Ipix on the move (IOM).
If there were no protocols what would be the point of the FDA. Another one of your completely mad ideas.
IOM.
He originally wanted interim data for which your FDA statement covers pretty explicitly. He is as usual, making a mountain out of a molehill.
The FDA and Ipix agreed to the trial size and whether you think it small or not is immaterial.
IOM.
What it is really saying is: “don’t be surprised if it works.”
IOM
Look Dunn you are wrong about Leo not being confidant, remember he can’t just get up and change the timelines. Ipix is on the move. IOM
What a terrible response. It is neither weak nor indefensible, it is by the book and by FDA guidelines.
He’s preparing for UC and preparing for further progress by Alfasigma not to mention the new pill form Brilacidin. GMU presentation may get some buzz ahead of it. IOM.
None of anything you said was Leo’s fault.
Hey ranger just remember you have nothing to gain from a successful trial. Expect more and more interest in Brilacidin with grants being back on the table.
I view the government bio lab testing as absolutely invaluable to Ipix giving them more than a chance to to succeed with Brilacidin. I believe this is going to build into the sp and shares may become a lot harder to acquire. We’ll see what happens.
Just another one of those right wing conspiracies? Ha ha.